AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DORZOLAMIDE HYDROCHLORIDE

12 registrations across 5 African markets— 7 active

Markets with DORZOLAMIDE HYDROCHLORIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
OCULARIDE EYE DROPS (Each ml contains Dorzolamide Hydrochloride 2%w/v)🇬🇭GhanaactiveJul 2032
OCULARIDE EYE DROPS (Each ml contains Dorzolamide Hydrochloride 2%w/v)🇬🇭GhanaactiveJul 2032
OCULARIDE EYE DROPS
Eye Drops, Solution
🇰🇪KenyaBLISS GVS PHARMA LTDactiveFeb 2029
DORZODROP EYE DROPS (Each ml contains: Dorzolamide Hydrochloride 20mg)🇬🇭GhanaactiveDec 2028
DORZODROP EYE DROPS (Each ml contains: Dorzolamide Hydrochloride 20mg)🇬🇭GhanaactiveDec 2028
GOZOPT🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
CIPLASOPT CO🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
SOPTICO🇿🇦South AfricaMEDPRO PHARMACEUTICA (PTY) LTDsuspendedJul 2025
CIPLASOPT🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
DOREMBIC 2.0%W/V EYE DROPS
EYE DROPS
🇲🇼MalawiexpiredJun 2016
DORZOLAMIDE HYDROCHLORIDE
OPHTHALMIC DROPS
🇺🇬UgandaORANEactive
DORZOLAMIDE HYDROCHLORIDE
OPHTHALMIC DROPS
🇺🇬UgandaORANEactive

DORZOLAMIDE HYDROCHLORIDE in Africa — Regulatory Overview

DORZOLAMIDE HYDROCHLORIDE is registered across 5 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, South Africa, Uganda, Kenya and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 7 (58%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.